Teleflex Incorporated : PHARMAC - Proposal to list infusion devices supplied by Teleflex Medical New Zealand

PHARMAC is seeking feedback on a proposal to list medical devices supplied by Teleflex Medical New Zealand in Part III of Section H of the Pharmaceutical Schedule from 1 December 2020.

We propose to list medical devices in the following categories: a range of non-dedicated & consumable infusion devices ('infusion devices') through a non-exclusive provisional agreement with Teleflex Medical New Zealand ('Teleflex')

Consultation closes at 4pm Monday 2 November 2020 and feedback can be emailed to [e-mail].

What would the effect be

From 1 December 2020, Infusion Devices supplied by Teleflex would be listed under a proposed national agreement for all DHB hospitals to purchase under, subject to consultation and approval by PHARMAC's Board or delegate ('Agreement').

The Agreement would not be for sole supply and DHBs could continue to purchase other suppliers' brands of products in the Infusion Devices category.

The Agreement would supersede any existing DHB contracts with Teleflex for the products included in the Agreement. Any product listed in the Agreement and purchased by a DHB would be in accordance with the terms and conditions, including price, stated in the Agreement effective from the date of listing on the Pharmaceutical Schedule.

Teleflex would provide appropriate educational services that would be tailored to the individual needs of DHBs, in formats and at times as required by DHBs.

Pricing for the devices in this Agreement, subject to any prior termination of the Agreement, would not be increased without prior consultation and approval by PHARMAC.

About the infusion devices

Infusion devices are medical devices used, or associated with devices used, in the infusion of fluids such as medications, intravenous solutions (such as saline, glucose, and electrolyte solutions), blood, total parenteral nutrition (TPN) solutions into the body. This includes medical devices used in intravenous therapy as well as other infusion therapies.

PHARMAC's infusion devices category includes: non-dedicated and consumable infusion devices not associated with infusion equipment and infusion equipment and associated devices.

Why we're proposing this

In 2018 PHARMAC issued a Request for Proposals for: supply of infusion devices (including non-dedicated and consumable infusion devices and infusion equipment and associated devices)

The RFP was for non-exclusive national agreements for listing on the Pharmaceutical Schedule.

PHARMAC has been working with suppliers who responded to the RFP, and proposals were progressed to contract negotiation, to seek provisional agreements. This proposal is the latest to arise from this process and we expect to consult on further provisional agreements with suppliers of Infusion Devices throughout 2020 and 2021.

Details about our proposal

PHARMAC has entered into a provisional agreement with Teleflex for the supply of infusion devices. The proposal would result in Pharmaceutical Schedule listings for: 121 non-dedicated & consumable infusion devices supplied by Teleflex under the brand names Arrow, Arrow International, Arrow AutoFuser, Arrow EZ-IO, Arrowg+ard Blue, and Arrowg+ard Blue Plus

Contact:

Tel: [phone]

Email: [e-mail]

(C) 2020 Electronic News Publishing, source ENP Newswire